BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 3572982)

  • 1. O-carbamoylsalicylates: agents for modification of hemoglobins.
    Parameswaran KN; Shi GY; Klotz IM
    J Med Chem; 1987 May; 30(5):936-9. PubMed ID: 3572982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diaspirins of methylenecitric acid.
    Massil SE; Shi GY; Klotz IM
    J Pharm Sci; 1984 Mar; 73(3):418-20. PubMed ID: 6716258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alternative diaspirins for modification of hemoglobin and sickle hemoglobin.
    Delaney EJ; Massil SE; Shi GY; Klotz IM
    Arch Biochem Biophys; 1984 Feb; 228(2):627-38. PubMed ID: 6696450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electrostatic effects in acylation of hemoglobin by aspirins.
    Massil SE; Shi GY; Klotz IM
    J Pharm Sci; 1984 Dec; 73(12):1851-3. PubMed ID: 6527276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel analgesic-antiinflammatory salicylates.
    Hannah J; Ruyle WV; Jones H; Matzuk AR; Kelly KW; Witzel BE; Holtz WJ; Houser RA; Shen TY; Sarett LH
    J Med Chem; 1978 Nov; 21(11):1093-100. PubMed ID: 309947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acylation of hemoglobin by aspirin-like diacyl esters.
    Massil SE; Shi GY; Klotz IM
    J Pharm Sci; 1984 Jul; 73(7):1013-4. PubMed ID: 6470944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis, and testing of potential antisickling agents. 1. Halogenated benzyloxy and phenoxy acids.
    Abraham DJ; Mehanna AS; Williams FL
    J Med Chem; 1982 Sep; 25(9):1015-7. PubMed ID: 7131479
    [No Abstract]   [Full Text] [Related]  

  • 8. Design, synthesis, and testing of potential antisickling agents. 5. Disubstituted benzoic acids designed for the donor site and proline salicylates designed for the acceptor site.
    Abraham DJ; Gazze DM; Kennedy PE; Mokotoff M
    J Med Chem; 1984 Dec; 27(12):1549-59. PubMed ID: 6094807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rational approaches to chemotherapy: antisickling agents.
    Klotz IM; Haney DN; King LC
    Science; 1981 Aug; 213(4509):724-31. PubMed ID: 7256275
    [No Abstract]   [Full Text] [Related]  

  • 10. Aryloxyalkanoic Acids as Non-Covalent Modifiers of the Allosteric Properties of Hemoglobin.
    Omar AM; Mahran MA; Ghatge MS; Bamane FH; Ahmed MH; El-Araby ME; Abdulmalik O; Safo MK
    Molecules; 2016 Aug; 21(8):. PubMed ID: 27529207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemical modification of human hemoglobin by antisickling concentrations of nitrogen mustard.
    Roth EF; Arnone A; Bookchin RM; Nagel RL
    Blood; 1981 Aug; 58(2):300-8. PubMed ID: 7248523
    [No Abstract]   [Full Text] [Related]  

  • 12. Quantitative structure-activity relationships of anticonvulsant aralkyl and alkyl carbamates.
    Tanaka M; Horisaka K; Yamagami C; Takao N; Fujita T
    Chem Pharm Bull (Tokyo); 1985 Jun; 33(6):2403-10. PubMed ID: 4064199
    [No Abstract]   [Full Text] [Related]  

  • 13. Fibrinolytic congeners of benzoic and salicylic acid. A mathematical analysis of correlation between structure and activity.
    Hansch C; von Kaulla KN
    Biochem Pharmacol; 1970 Jul; 19(7):2193-200. PubMed ID: 5520369
    [No Abstract]   [Full Text] [Related]  

  • 14. Syntheses and biological activities of N-alkyl- and N-alkenylcarbamoyl phospholipids.
    Tsushima S; Yoshioka Y; Tanida S; Nomura H; Nojima S; Hozumi M
    Chem Pharm Bull (Tokyo); 1984 Jul; 32(7):2700-13. PubMed ID: 6437690
    [No Abstract]   [Full Text] [Related]  

  • 15. Discovery of diflunisal.
    Hannah J; Ruyle WV; Jones H; Matzuk AR; Kelly KW; Witzel BE; Holtz WJ; Houser RW; Shen TY; Sarett LH
    Br J Clin Pharmacol; 1977 Feb; 4 Suppl 1(Suppl 1):7S-13S. PubMed ID: 328036
    [No Abstract]   [Full Text] [Related]  

  • 16. Modification of hemoglobin by ninhydrin.
    Kokkini G; Stevens VJ; Peterson CM; Cerami A
    Blood; 1980 Oct; 56(4):701-5. PubMed ID: 7417710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allosteric modifiers of hemoglobin. 1. Design, synthesis, testing, and structure-allosteric activity relationship of novel hemoglobin oxygen affinity decreasing agents.
    Randad RS; Mahran MA; Mehanna AS; Abraham DJ
    J Med Chem; 1991 Feb; 34(2):752-7. PubMed ID: 1995897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Piperazine derivatives of benzimidazole as potential anthelmintics. Part 1: Synthesis and activity of methyl-5-(4-substituted piperazin-1-yl)benzimidazole-2-carbamates.
    Sánchez-Alonso RM; Raviña E; Santana L; García-Mera G; Sanmartín M; Baltar P
    Pharmazie; 1989 Sep; 44(9):606-7. PubMed ID: 2608706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of anti-inflammatory drugs upon the chemistry and enzymology of rat skin.
    Houck JC; Patel YM; Gladner J
    Biochem Pharmacol; 1967 Jun; 16(6):1099-111. PubMed ID: 6040391
    [No Abstract]   [Full Text] [Related]  

  • 20. Studies on reconstituted myoglobins and hemoglobins. II. Role of the heme side chains in the oxygenation of hemoglobin.
    Kawabe K; Imaizumi K; Yoshida Z; Imai K; Tyuma I
    J Biochem; 1982 Dec; 92(6):1713-22. PubMed ID: 7161257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.